AgomAb Therapeutics NV - ADR

XNAS: AGMB

Download real time

13.08 0.05 (0.38%)

26.60% Fall from 52W High

47,228

XNAS Volume

XNAS 10 Jul, 2026 5:30 PM (EDT)

AgomAb Therapeutics NV ADR quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents